Last10K.com

Aehr Test Systems (AEHR) SEC Filing 10-Q Quarterly Report for the period ending Tuesday, November 30, 2021

Aehr Test Systems

CIK: 1040470 Ticker: AEHR

EXHIBIT 99.1

 

 

FOR IMMEDIATE RELEASE

 

Contacts:

 

 

 

Aehr Test Systems

MKR Investor Relations Inc.

Ken Spink

Todd Kehrli or Jim Byers

Chief Financial Officer

Analyst/Investor Contact

(510) 623-9400 x309

(323) 468-2300

 

aehr@mkr-group.com

  

Aehr Test Reports Second Consecutive Quarter of Record Bookings in Second Quarter of

Fiscal 2022 on Strength of Semiconductor Test and Burn-In Sales for Electric Vehicles

 

Fremont, CA (January 6, 2022)

– Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced financial results for its second quarter of fiscal 2022 ended November 30, 2021.

 

Fiscal Second Quarter Financial Results:

 

 

·

Net sales were $9.6 million, up 471% from $1.7 million in the second quarter of fiscal 2021.

 

·

GAAP net income was $717,000, or $0.03 per diluted share, compared to a GAAP net loss of $2.0 million, or $0.08 per diluted share, in the second quarter of fiscal 2021.

 

·

Non-GAAP net income was $1.4 million, or $0.05 per diluted share, which excludes the impact of stock-based compensation, compared to a non-GAAP net loss of $1.7 million, or $0.07 per diluted share, in the second quarter of fiscal 2021.

 

·

Bookings were $29.1 million for the quarter ended November 30, 2021, the Company’s quarterly highest bookings on record, compared to $1.6 million in the second quarter of fiscal 2021.

 

·

Backlog as of November 30, 2021 was $36.1 million, the Company’s highest backlog on record.

 

Fiscal First Six Months Financial Results:

 

 

·

Net sales were $15.3 million, up 313% from $3.7 million in the first six months of fiscal 2021.

 

·

GAAP net income was $1.4 million, or $0.05 per diluted share, which includes the impact of forgiveness of $1.7 million in loans from the Paycheck Protection Program (“PPP”) received in fiscal 2020. This compares to a GAAP net loss of $1.9 million, or $0.08 per diluted share, in the first six months of fiscal 2021, which includes the impact of stock-based compensation and a non-cash net gain of $2.2 million and tax benefit of $215,000 related to the closure of Aehr’s Japan subsidiary during the first quarter of fiscal 2021.

 

·

Non-GAAP net income was $1.0 million, or $0.04 per diluted share, which excludes the impact of stock-based compensation and forgiveness of the PPP loan. This compares to a non-GAAP net loss of $3.7 million, or $0.16 per diluted share, in the first six months of fiscal 2021, which excludes the impact of stock-based compensation and the net gain related to the closure of Aehr’s Japan subsidiary during the first quarter of fiscal 2021.

 

An explanation of the use of non-GAAP financial measures and a reconciliation of Aehr’s non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying tables.

 

 

 

 

Aehr Test Systems Reports Second Quarter Fiscal 2022 Financial Results

January 6, 2022

Page 2 of 7 

 

Gayn Erickson, President and CEO of Aehr Test Systems, commented:

 

“We finished the second quarter with record bookings for a single quarter of $29.1 million and our highest backlog on record of $36.1 million. Including the announced orders since the beginning of the fiscal third quarter, our total bookings for the fiscal year to date is over $52 million.

 

“We continue to see very strong interest and demand for wafer level test and burn-in of silicon carbide devices, particularly for use directly in, and in support of, the electric vehicle market. We are ramping our FOXTM multi-wafer test and burn-in systems and full wafer WaferPakTM capacity to meet this upcoming silicon carbide market opportunity, which we believe will grow significantly over the next decade or more. We are only at the very beginning of this ramp as electric vehicles accounted for a very small percentage share of the overall market last year and are expected to be over 30% of total vehicles sold by 2030.

 

“During the quarter we received a $19.4 million order for our FOX-XPTM wafer level test and burn-in systems from our lead silicon carbide customer. This order was then followed by a $7.6 million order for WaferPaks that do not fully populate the systems, so we are expecting additional follow on WaferPak orders for these production FOX-XP systems. These systems and WaferPaks are being used to test and burn-in MOSFET devices in traction inverters in electric vehicle motor controllers, as well as both on-board and off-board electric vehicle chargers. This customer, a major automotive semiconductor supplier with a significant customer base in the automotive semiconductor market, continues to forecast significant additional system and WaferPak purchases over the next several years. Multiple industry forecasters and analysts expect the market for silicon carbide devices to grow at a compound annual growth rate (CAGR) of more than 30% over the next decade driven by demand from the electric vehicle market and other applications.

 

“In addition to a very strong backlog and forecast from our lead silicon carbide customer, we are currently engaged in discussions and/or evaluations with several other silicon carbide suppliers regarding their wafer level test and burn-in needs. This includes at least one large silicon carbide supplier that has moved to on-wafer evaluation and benchmarking of Aehr’s FOX-XP multi-wafer system for testing and burning in their silicon carbide wafers. We believe we will add several new silicon carbide customers that will ramp into production by next fiscal year on our solutions.

 

“Another positive is that we continue to see signs of strengthening in the silicon photonics test and burn-in market as our FOX multi-wafer systems and WaferPaks provide a very cost effective and scalable solution for “burning in” the optical lasers and stabilizing their output power while also removing any extrinsic or early life failures. In addition to the silicon photonics devices that are now ramping into production for fiberoptic transceivers for datacom and telecom applications such as data center and 5G infrastructure, several companies have made public announcements of their intent to integrate silicon photonics devices and co-packaged optics in high end processor applications and intra-chip as well as inter-chip communications within the next few years.

 

“During the last few months, we received orders from a current silicon photonics customer for six additional FOX-NP™ systems to support the characterization and product qualification of new types of photonics-based devices. This customer is expected to purchase new sets of WaferPaks to be used with these systems. As the applications and market for silicon photonics-based devices continue to grow, we expect this customer to continue to increase their capacity in the future.

 

 

 

 

Aehr Test Systems Reports Second Quarter Fiscal 2022 Financial Results

January 6, 2022

Page 3 of 7

 

“Several other customers addressing the silicon photonics market have also forecast additional FOX system and WaferPak or DiePak® contactor capacity needs over the next 12 months. These include needs to address incremental production capacity as well as capacity to address new customer and new product qualification and engineering. Silicon photonics devices address the 5G and data center infrastructure industry as well as several other key markets today, and Yole Research predicts that the silicon photonics transceiver market alone will reach $4.6 billion in 2026, with a CAGR of 25% between 2021 and 2026.

 

“We remain very focused on serving the very large market opportunities we see ahead, which include the significant opportunity for test and burn-in of silicon carbide devices for electric vehicles and electrification infrastructure, silicon photonics devices for data center and 5G infrastructure, and 2D/3D sensors for mobile and wearable devices. With our record bookings and the strength of our semiconductor test and burn-in solutions, we are confident in our ability to deliver significant revenue growth and are reiterating our guidance for revenue for the year.”

 

Fiscal 2022 Financial Guidance:

 

For the fiscal year ending May 31, 2022, Aehr is reiterating its previously provided guidance for full year total revenue of at least $50 million, and to be profitable for the fiscal year at these revenue levels based upon its operating model.

 

Management Conference Call and Webcast

 

Aehr Test Systems will host a conference call and webcast today at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss its fiscal 2022 second quarter operating results. To access the live call, dial 800-437-2398 (US and Canada) or +1 929-477-0577 (International) and give the participant passcode 5907605. In addition, a live and archived webcast of the conference call will be available over the Internet at www.aehr.com in the Investor Relations section and at the following link https://edge.media-server.com/mmc/p/ewc7mhgg. A replay of the conference call will also be available via telephone beginning approximately two hours after conclusion of the call through 8:00 p.m. ET on January 13, 2022. To access the replay dial-in information, please click here.

 

About Aehr Test Systems

 

Headquartered in Fremont, California, Aehr Test Systems is a worldwide provider of test systems for burning-in and testing logic, optical and memory integrated circuits and has installed over 2,500 systems worldwide. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products in package, wafer level, and singulated die/module level test. Aehr Test has developed and introduced several innovative products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The ABTS system is used in production and qualification testing of packaged parts for both lower power and higher power logic devices as well as all common types of memory devices. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems used for burn-in and functional test of complex devices, such as leading-edge memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices. The FOX-CP system is a new low-cost single-wafer compact test and reliability verification solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The WaferPak Contactor contains a unique full wafer probe card capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems. The DiePak Carrier is a reusable, temporary package that enables IC manufacturers to perform cost-effective final test and burn-in of both bare die and modules. For more information, please visit Aehr Test Systems’ website at www.aehr.com.

 

 

 

 

Aehr Test Systems Reports Second Quarter Fiscal 2022 Financial Results

January 6, 2022

Page 4 of 7

 

Safe Harbor Statement


This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr’s future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “going to,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “sees,” or “continue,” or the negative of these words or other similar terms or expressions that concern Aehr’s expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, Aehr’s ability to generate bookings and revenue increases in the future, including the first quarter of fiscal 2022; future requirements and orders of Aehr’s new and existing customers; bookings forecasted for proprietary WaferPakTM and DiePak consumables across multiple market segments; the temporary nature of customer pushouts; shipping timelines for products and follow-on capacity orders; the growth of Aehr’s systems and consumables, including as a percentage of total sales; financial guidance for fiscal 2022, including related to revenue and profitability, and expectations regarding fiscal 2022; Aehr’s ability to expand its number of customers using its FOX-PTM solutions; the ability to secure potential customer engagements; expectations related to long-term demand for Aehr’s productions and the attractiveness of key markets; the belief that Aehr will be stronger after the current worldwide COVID-19 pandemic, including expectations related to greater production, more customers, more applications, and higher value products. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr’s recent 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.

 

– Financial Tables to Follow –

 

 

 

 

Aehr Test Systems Reports Second Quarter Fiscal 2022 Financial Results

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

January 6, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Page 5 of 7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AEHR TEST SYSTEMS AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

Nov 30,

 

 

Aug 31,

 

 

Nov 30,

 

 

Nov 30,

 

 

Nov 30,

 

 

 

2021

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$ 9,611

 

 

$ 5,646

 

 

$ 1,683

 

 

$ 15,257

 

 

$ 3,695

 

Cost of sales

 

 

5,092

 

 

 

3,365

 

 

 

1,306

 

 

 

8,457

 

 

 

3,091

 

Gross profit

 

 

4,519

 

 

 

2,281

 

 

 

377

 

 

 

6,800

 

 

 

604

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

2,489

 

 

 

1,953

 

 

 

1,501

 

 

 

4,442

 

 

 

3,015

 

Research and development

 

 

1,313

 

 

 

1,321

 

 

 

820

 

 

 

2,634

 

 

 

1,720

 

Total operating expenses

 

 

3,802

 

 

 

3,274

 

 

 

2,321

 

 

 

7,076

 

 

 

4,735

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

 

717

 

 

 

(993 )

 

 

(1,944 )

 

 

(276 )

 

 

(4,131 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

(1 )

 

 

(9 )

 

 

(12 )

 

 

(10 )

 

 

(25 )

Income from forgiveness of PPP loan

 

 

-

 

 

 

1,698

 

 

 

-

 

 

 

1,698

 

 

 

-

 

Net gain from dissolution of Aehr Test Systems Japan

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,186

 

Other income (expense), net

 

 

35

 

 

 

23

 

 

 

(6 )

 

 

58

 

 

 

(100 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before income tax (expense) benefit

 

 

751

 

 

 

719

 

 

 

(1,962 )

 

 

1,470

 

 

 

(2,070 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax (expense) benefit

 

 

(34 )

 

 

(23 )

 

 

(4 )

 

 

(57 )

 

 

211

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$ 717

 

 

$ 696

 

 

$ (1,966 )

 

$ 1,413

 

 

$ (1,859 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$ 0.03

 

 

$ 0.03

 

 

$ (0.08 )

 

$ 0.06

 

 

$ (0.08 )

Diluted

 

$ 0.03

 

 

$ 0.03

 

 

$ (0.08 )

 

$ 0.05

 

 

$ (0.08 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares used in per share calculations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

26,205

 

 

 

23,999

 

 

 

23,396

 

 

 

25,102

 

 

 

23,322

 

Diluted

 

 

28,342

 

 

 

25,356

 

 

 

23,396

 

 

 

26,849

 

 

 

23,322

 

 

-more-

 

 

 

 

Aehr Test Systems Reports Second Quarter Fiscal 2022 Financial Results

 

 

 

 

 

 

 

 

 

 

January 6, 2022

 

 

 

 

 

 

 

 

 

 

Page 6 of 7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AEHR TEST SYSTEMS AND SUBSIDIARIES

Reconciliation of GAAP and Non-GAAP Results

(in thousands, except per share data)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

Nov 30,

 

 

Aug 31,

 

 

Nov 30,

 

 

Nov 30,

 

 

Nov 30,

 

 

 

2021

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net income (loss)

 

$ 717

 

 

$ 696

 

 

$ (1,966 )

 

$ 1,413

 

 

$ (1,859 )

Stock-based compensation expense

 

 

718

 

 

 

588

 

 

 

257

 

 

 

1,306

 

 

 

527

 

Income from forgiveness of PPP loan

 

 

-

 

 

 

(1,698 )

 

 

-

 

 

 

(1,698 )

 

 

-

 

Income from disolution of Aehr Test Systesm Japan

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,401 )

Non-GAAP net income (loss)

 

$ 1,435

 

 

$ (414 )

 

$ (1,709 )

 

$ 1,021

 

 

$ (3,733 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net income (loss) per diluted share

 

$ 0.03

 

 

$ 0.03

 

 

$ (0.08 )

 

$ 0.05

 

 

$ (0.08 )

Non-GAAP net income (loss) per diluted share

 

$ 0.05

 

 

$ (0.02 )

 

$ (0.07 )

 

$ 0.04

 

 

$ (0.16 )

Shares used in GAAP diluted shares calculation

 

 

28,342

 

 

 

25,356

 

 

 

23,396

 

 

 

26,849

 

 

 

23,322

 

Shares used in non-GAAP diluted shares calculation

 

 

28,342

 

 

 

23,999

 

 

 

23,396

 

 

 

26,849

 

 

 

23,322

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP net income (loss) is a non-GAAP measure and should not be considered a replacement for GAAP results. Non-GAAP net income (loss) is a financial measure the Company uses to evaluate the underlying results and operating performance of the business. The limitation of this measure is that it excludes items that impact the Company's current period net income. This limitation is best addressed by using this measure in combination with net income (loss) (the most directly comparable GAAP financial measure). These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies.
 
We believe these measures enhance investors’ ability to review the company’s business from the same perspective as the Company’s management and facilitate comparisons of this period’s results with prior periods.

 

-more-

 

 

 

 

Aehr Test Systems Reports Second Quarter Fiscal 2022 Financial Results

 

 

 

 

 

 

January 6, 2022

 

 

 

 

 

 

Page 7 of 7

 

 

 

 

 

 

 

 

 

 

 

 

 

AEHR TEST SYSTEMS AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands, except per share data)

(unaudited)

 

 

 

 

 

 

 

 

 

November 30,

 

 

August 31,

 

 

May 31,

 

 

 

2021

 

 

2021

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$ 35,031

 

 

$ 6,530

 

 

$ 4,582

 

Accounts receivable, net

 

 

7,391

 

 

 

4,264

 

 

 

5,202

 

Inventories

 

 

13,033

 

 

 

10,146

 

 

 

8,849

 

Prepaid expenses and other

 

 

622

 

 

 

759

 

 

 

551

 

Total current assets

 

 

56,077

 

 

 

21,699

 

 

 

19,184

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

661

 

 

 

676

 

 

 

677

 

Operating lease right-of-use assets

 

 

1,265

 

 

 

1,437

 

 

 

1,606

 

Other assets

 

 

182

 

 

 

189

 

 

 

198

 

Total assets

 

$ 58,185

 

 

$ 24,001

 

 

$ 21,665

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$ 3,386

 

 

$ 2,753

 

 

$ 2,893

 

Accrued expenses

 

 

2,254

 

 

 

1,978

 

 

 

2,163

 

Operating lease liabilities, short-term

 

 

763

 

 

 

750

 

 

 

737

 

Customer deposits and deferred revenue, short-term

 

 

10,142

 

 

 

3,279

 

 

 

189

 

Line of credit

 

 

-

 

 

 

-

 

 

 

1,400

 

Current portion of long-term debt

 

 

-

 

 

 

-

 

 

 

1,679

 

Total current liabilities

 

 

16,545

 

 

 

8,760

 

 

 

9,061

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating lease liabilities, long-term

 

 

616

 

 

 

813

 

 

 

1,007

 

Long-term debt, net of current portion

 

 

-

 

 

 

-

 

 

 

-

 

Deferred revenue, long-term

 

 

116

 

 

 

150

 

 

 

99

 

Other liabilities

 

 

46

 

 

 

46

 

 

 

49

 

Total liabilities

 

 

17,323

 

 

 

9,769

 

 

 

10,216

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total shareholders' equity

 

 

40,862

 

 

 

14,232

 

 

 

11,449

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities and shareholders' equity

 

$ 58,185

 

 

$ 24,001

 

 

$ 21,665

 

 

 

# # #

 


The following information was filed by Aehr Test Systems (AEHR) on Thursday, January 6, 2022 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Aehr Test Systems's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aehr Test Systems.

Continue

Assess how Aehr Test Systems's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aehr Test Systems's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Revenue
Financial
Other
Filter Subcategory:
All
Product
Earnings
Income
Expense
Geography
Debt
Shares
Other
Inside Aehr Test Systems's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows (Unaudited)
Condensed Consolidated Statements Of Comprehensive Income (Loss) (Unaudited)
Condensed Consolidated Statements Of Operations (Unaudited)
Condensed Consolidated Statements Of Shareholders Equity (Unaudited)
Accounts Receivable (Details Narrative)
Accounts Receivable Net
Basis Of Presentation And Summary Of Significant Acccounting Policies
Basis Of Presentation And Summary Of Significant Acccounting Policies (Policies)
Borrowing And Financing Arrangements
Borrowing And Financing Arrangements (Details Narrative)
Customer Deposits And Deferred Revenue Short-Term
Customer Deposits And Deferred Revenue Short-Term (Details)
Customer Deposits And Deferred Revenue Short-Term (Tables)
Dissolution Of Aehr Test Systems Japan
Dissolution Of Aehr Test Systems Japan (Details Narrative)
Earnings Per Share
Earnings Per Share (Details Narrative)
Earnings Per Share (Details)
Earnings Per Share (Tables)
Equity
Equity (Details Narrative)
Fair Value Of Financial Instruments
Fair Value Of Financial Instruments (Details Narrative)
Fair Value Of Financial Instruments (Details)
Fair Value Of Financial Instruments (Tables)
Income Taxes
Income Taxes (Details Narrative)
Inventories
Inventories (Details)
Inventories (Tables)
Leases
Leases (Details 1)
Leases (Details Narrative)
Leases (Details)
Leases (Tables)
Long-Term Debt (Details Narrative)
Longterm Debt
Product Warranties
Product Warranties (Details Narrative)
Product Warranties (Details)
Product Warranties (Tables)
Recent Accounting Pronouncements
Recent Accounting Pronouncements (Policies)
Revenue
Revenue (Details 1)
Revenue (Details 2)
Revenue (Details Narrative)
Revenue (Details)
Revenue (Tables)
Segment And Concentration Information (Details)
Segment Information
Segment Information (Details Narrative)
Segment Information (Tables)
Stock-Based Compensation
Stock-Based Compensation (Details 1)
Stock-Based Compensation (Details 2)
Stock-Based Compensation (Details 3)
Stock-Based Compensation (Details 4)
Stock-Based Compensation (Details Narrative)
Stock-Based Compensation (Details)
Stockbased Compensation (Tables)
Ticker: AEHR
CIK: 1040470
Form Type: 10-Q Quarterly Report
Accession Number: 0001654954-22-000518
Submitted to the SEC: Fri Jan 14 2022 4:08:39 PM EST
Accepted by the SEC: Fri Jan 14 2022
Period: Tuesday, November 30, 2021
Industry: Instruments For Meas And Testing Of Electricity And Elec Signals

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/aehr/0001654954-22-000518.htm